HEADER IMMUNE SYSTEM/VIRAL PROTEIN 23-JAN-22 7WP8 TITLE CRYO-EM STRUCTURE OF SARS-COV-2 RECOMBINANT SPIKE PROTEIN STFK1628X IN TITLE 2 COMPLEX WITH THREE NEUTRALIZING ANTIBODIES CAVEAT 7WP8 VAL F 503 HAS WRONG CHIRALITY AT ATOM CA COMPND MOL_ID: 1; COMPND 2 MOLECULE: 83H7 LIGHT CHAIN; COMPND 3 CHAIN: C; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: 83H7 HEAVY CHAIN; COMPND 6 CHAIN: D; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: 2B4 HEAVY CHAIN; COMPND 9 CHAIN: E; COMPND 10 MOL_ID: 4; COMPND 11 MOLECULE: SPIKE GLYCOPROTEIN; COMPND 12 CHAIN: F; COMPND 13 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 5; COMPND 16 MOLECULE: 2B4 LIGHT CHAIN; COMPND 17 CHAIN: G; COMPND 18 MOL_ID: 6; COMPND 19 MOLECULE: 85F7 HEAVY CHAIN; COMPND 20 CHAIN: H; COMPND 21 MOL_ID: 7; COMPND 22 MOLECULE: 85F7 LIGHT CHAIN; COMPND 23 CHAIN: L SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_TAXID: 10090; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 6 ORGANISM_TAXID: 10090; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 9 ORGANISM_TAXID: 10090; SOURCE 10 MOL_ID: 4; SOURCE 11 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 12 2; SOURCE 13 ORGANISM_TAXID: 2697049; SOURCE 14 GENE: S, 2; SOURCE 15 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 17 MOL_ID: 5; SOURCE 18 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 19 ORGANISM_TAXID: 10090; SOURCE 20 MOL_ID: 6; SOURCE 21 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 22 ORGANISM_TAXID: 10090; SOURCE 23 MOL_ID: 7; SOURCE 24 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 25 ORGANISM_TAXID: 10090 KEYWDS SARS-COV-2, SPIKE, VACCINE, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL KEYWDS 2 PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR Q.ZHENG,H.SUN,Q.YUAN,S.LI,N.XIA REVDAT 2 13-SEP-23 7WP8 1 JRNL REVDAT 1 08-MAR-23 7WP8 0 JRNL AUTH Y.WU,S.WANG,Y.ZHANG,L.YUAN,Q.ZHENG,M.WEI,Y.SHI,Z.WANG,J.MA, JRNL AUTH 2 K.WANG,M.NIE,J.XIAO,Z.HUANG,P.CHEN,H.GUO,M.LAN,J.XU,W.HOU, JRNL AUTH 3 Y.HONG,D.CHEN,H.SUN,H.XIONG,M.ZHOU,C.LIU,W.GUO,H.GUO,J.GAO, JRNL AUTH 4 C.GAN,Z.LI,H.ZHANG,X.WANG,S.LI,T.CHENG,Q.ZHAO,Y.CHEN,T.WU, JRNL AUTH 5 T.ZHANG,J.ZHANG,H.CAO,H.ZHU,Q.YUAN,Y.GUAN,N.XIA JRNL TITL LINEAGE-MOSAIC AND MUTATION-PATCHED SPIKE PROTEINS FOR JRNL TITL 2 BROAD-SPECTRUM COVID-19 VACCINE. JRNL REF CELL HOST MICROBE V. 30 1732 2022 JRNL REFN ESSN 1934-6069 JRNL PMID 36323313 JRNL DOI 10.1016/J.CHOM.2022.10.011 REMARK 2 REMARK 2 RESOLUTION. 3.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.880 REMARK 3 NUMBER OF PARTICLES : 115589 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7WP8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1300027197. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYO-EM STRUCTURE OF SARS-COV-2 REMARK 245 RECOMBINANT SPIKE PROTEIN REMARK 245 STFK1628X IN COMPLEX WITH THREE REMARK 245 NEUTRALIZING ANTIBODIES; REMARK 245 NEUTRALIZING ANTIBODIES; SPIKE REMARK 245 PROTEIN STFK1628X REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TECNAI F30 REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEPTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, E, F, G, H, L, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLN F 498 C PRO F 499 N -0.132 REMARK 500 VAL F 503 CA VAL F 503 CB -0.143 REMARK 500 VAL F 503 CA VAL F 503 C -0.189 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO F 499 C - N - CA ANGL. DEV. = 10.0 DEGREES REMARK 500 PRO F 499 C - N - CD ANGL. DEV. = -14.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA C 51 -6.96 66.02 REMARK 500 SER C 52 -31.33 -132.65 REMARK 500 ALA E 16 -167.61 -127.01 REMARK 500 GLU E 42 15.43 53.89 REMARK 500 ASP E 66 26.42 48.35 REMARK 500 THR E 77 57.19 38.66 REMARK 500 ALA F 352 63.89 -101.49 REMARK 500 TYR F 369 14.91 53.40 REMARK 500 LYS F 386 51.37 -97.90 REMARK 500 ASN F 394 60.71 36.47 REMARK 500 ASN F 422 -51.36 -121.45 REMARK 500 TYR F 449 -3.85 68.37 REMARK 500 LEU G 29 50.03 -91.04 REMARK 500 TYR G 55 -156.46 -85.89 REMARK 500 PHE G 56 -69.93 -26.39 REMARK 500 ALA G 57 -57.87 -123.97 REMARK 500 SER G 71 -168.43 -161.54 REMARK 500 ASP G 88 57.15 -96.06 REMARK 500 ILE H 48 -55.50 -126.35 REMARK 500 VAL H 56 95.66 -65.98 REMARK 500 GLU H 100 -30.17 -133.52 REMARK 500 HIS H 101 36.57 -94.52 REMARK 500 ALA L 25 -163.25 -108.17 REMARK 500 ASN L 26 -80.67 -134.52 REMARK 500 TRP L 46 -60.02 -102.19 REMARK 500 THR L 50 -41.34 -133.32 REMARK 500 SER L 51 28.33 -142.39 REMARK 500 ALA L 82 57.20 -97.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR G 55 PHE G 56 -132.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLN F 498 -12.72 REMARK 500 VAL F 503 -10.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-32678 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SARS-COV-2 RECOMBINANT SPIKE PROTEIN STFK1628X REMARK 900 IN COMPLEX WITH THREE NEUTRALIZING ANTIBODIES DBREF 7WP8 C 3 106 PDB 7WP8 7WP8 3 106 DBREF 7WP8 D 3 120 PDB 7WP8 7WP8 3 120 DBREF 7WP8 E 1 119 PDB 7WP8 7WP8 1 119 DBREF 7WP8 F 336 518 UNP P0DTC2 SPIKE_SARS2 336 518 DBREF 7WP8 G 1 113 PDB 7WP8 7WP8 1 113 DBREF 7WP8 H 1 118 PDB 7WP8 7WP8 1 118 DBREF 7WP8 L 1 106 PDB 7WP8 7WP8 1 106 SEQADV 7WP8 THR F 417 UNP P0DTC2 LYS 417 ENGINEERED MUTATION SEQADV 7WP8 ARG F 452 UNP P0DTC2 LEU 452 ENGINEERED MUTATION SEQADV 7WP8 LYS F 478 UNP P0DTC2 THR 478 VARIANT SEQADV 7WP8 LYS F 484 UNP P0DTC2 GLU 484 ENGINEERED MUTATION SEQADV 7WP8 TYR F 501 UNP P0DTC2 ASN 501 VARIANT SEQRES 1 C 104 VAL MET THR GLN SER HIS LYS PHE LEU SER THR SER VAL SEQRES 2 C 104 GLY ASP ARG VAL ASN ILE THR CYS LYS ALA SER GLN ASP SEQRES 3 C 104 VAL ASP THR ALA VAL ALA TRP TYR GLN GLN LYS PRO GLY SEQRES 4 C 104 GLN SER PRO LYS LEU LEU ILE SER TRP ALA SER THR ARG SEQRES 5 C 104 HIS THR GLY VAL PRO ASP ARG PHE THR GLY SER GLY SER SEQRES 6 C 104 GLY THR ASP PHE THR LEU THR ILE SER ASN VAL GLN SER SEQRES 7 C 104 GLU ASP LEU ALA ASP TYR PHE CYS GLN GLN TYR SER PRO SEQRES 8 C 104 TYR PRO TYR THR PHE GLY GLY GLY THR LYS LEU GLU ILE SEQRES 1 D 118 GLN LEU ALA GLN SER GLY ALA GLU LEU ALA ARG PRO GLY SEQRES 2 D 118 ALA SER VAL LYS LEU SER CYS LYS ALA SER GLY TYR THR SEQRES 3 D 118 PHE THR ARG TYR TRP MET GLN TRP VAL LYS GLN ARG PRO SEQRES 4 D 118 GLY GLN GLY LEU GLU TRP ILE GLY ALA ILE TYR PRO GLY SEQRES 5 D 118 ASP GLY ASP SER ARG TYR THR GLN LYS PHE LYS GLY LYS SEQRES 6 D 118 ALA THR LEU THR ALA ASP LYS SER SER SER THR ALA TYR SEQRES 7 D 118 MET GLN LEU SER SER LEU ALA SER GLU ASP SER ALA VAL SEQRES 8 D 118 TYR TYR CYS ALA ARG ARG ASN TYR TYR GLY TYR ASP ALA SEQRES 9 D 118 PHE ALA TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 10 D 118 ALA SEQRES 1 E 119 GLN VAL GLN LEU GLN GLN PRO GLY ALA GLU LEU VAL ARG SEQRES 2 E 119 PRO GLY ALA SER VAL LYS LEU SER CYS LYS ALA SER GLY SEQRES 3 E 119 TYR THR PHE THR SER TYR TRP MET ASN TRP VAL LYS GLN SEQRES 4 E 119 ARG PRO GLU GLN GLY LEU GLU TRP ILE GLY ARG ILE ASP SEQRES 5 E 119 PRO TYR ASP SER GLU THR HIS TYR ASN GLN LYS PHE LYS SEQRES 6 E 119 ASP LYS ALA ILE LEU THR VAL ASP LYS SER SER THR THR SEQRES 7 E 119 ALA TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 E 119 ALA VAL TYR TYR CYS ALA ARG TRP GLY THR VAL GLU TRP SEQRES 9 E 119 PHE PHE ASP TYR TRP GLY GLN GLY THR THR LEU THR VAL SEQRES 10 E 119 SER GLN SEQRES 1 F 183 CYS PRO PHE GLY GLU VAL PHE ASN ALA THR ARG PHE ALA SEQRES 2 F 183 SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SER ASN CYS SEQRES 3 F 183 VAL ALA ASP TYR SER VAL LEU TYR ASN SER ALA SER PHE SEQRES 4 F 183 SER THR PHE LYS CYS TYR GLY VAL SER PRO THR LYS LEU SEQRES 5 F 183 ASN ASP LEU CYS PHE THR ASN VAL TYR ALA ASP SER PHE SEQRES 6 F 183 VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE ALA PRO GLY SEQRES 7 F 183 GLN THR GLY THR ILE ALA ASP TYR ASN TYR LYS LEU PRO SEQRES 8 F 183 ASP ASP PHE THR GLY CYS VAL ILE ALA TRP ASN SER ASN SEQRES 9 F 183 ASN LEU ASP SER LYS VAL GLY GLY ASN TYR ASN TYR ARG SEQRES 10 F 183 TYR ARG LEU PHE ARG LYS SER ASN LEU LYS PRO PHE GLU SEQRES 11 F 183 ARG ASP ILE SER THR GLU ILE TYR GLN ALA GLY SER LYS SEQRES 12 F 183 PRO CYS ASN GLY VAL LYS GLY PHE ASN CYS TYR PHE PRO SEQRES 13 F 183 LEU GLN SER TYR GLY PHE GLN PRO THR TYR GLY VAL GLY SEQRES 14 F 183 TYR GLN PRO TYR ARG VAL VAL VAL LEU SER PHE GLU LEU SEQRES 15 F 183 LEU SEQRES 1 G 113 ASP ILE VAL MET THR GLN SER PRO SER SER LEU ALA MET SEQRES 2 G 113 SER VAL GLY GLN LYS VAL THR MET SER CYS LYS SER SER SEQRES 3 G 113 GLN SER LEU LEU ASN SER TYR ASN GLN GLU ASN TYR LEU SEQRES 4 G 113 ALA TRP TYR GLN GLN LYS PRO GLY GLN SER PRO LYS LEU SEQRES 5 G 113 LEU VAL TYR PHE ALA SER THR ARG GLU SER GLY VAL PRO SEQRES 6 G 113 ASP ARG PHE ILE GLY SER GLY SER GLY THR ASP PHE THR SEQRES 7 G 113 LEU THR ILE SER SER VAL GLN ALA GLU ASP LEU ALA ASP SEQRES 8 G 113 TYR PHE CYS GLN GLN HIS TYR SER THR PRO PHE THR PHE SEQRES 9 G 113 GLY SER GLY THR LYS LEU GLU ILE LYS SEQRES 1 H 118 GLN VAL GLN LEU GLN GLN SER GLY PRO GLU LEU VAL LYS SEQRES 2 H 118 PRO GLY ALA SER VAL ARG ILE SER CYS LYS ALA SER GLY SEQRES 3 H 118 TYR THR PHE THR SER TYR TYR ILE HIS TRP VAL LYS GLN SEQRES 4 H 118 ARG PRO GLY GLN GLY LEU GLU TRP ILE GLY TRP ILE TYR SEQRES 5 H 118 PRO GLY ASN VAL LYS SER ILE TYR ASN GLU LYS PHE LYS SEQRES 6 H 118 GLY LYS ALA THR LEU THR ALA ASP LYS SER SER ASN THR SEQRES 7 H 118 ALA TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 H 118 ALA VAL TYR PHE CYS ALA GLY GLU GLU HIS GLY ASN TYR SEQRES 9 H 118 PHE ASP PHE TRP GLY GLN GLY THR THR LEU THR VAL SER SEQRES 10 H 118 GLN SEQRES 1 L 106 GLN ILE VAL LEU SER GLN SER PRO THR ILE LEU SER ALA SEQRES 2 L 106 SER PRO GLY GLU LYS VAL THR MET THR CYS ARG ALA ASN SEQRES 3 L 106 SER SER VAL GLY PHE MET HIS TRP CYS GLN GLN LYS PRO SEQRES 4 L 106 GLY SER SER PRO LYS PRO TRP ILE TYR ALA THR SER ASN SEQRES 5 L 106 LEU ALA SER GLY VAL PRO GLY ARG PHE SER GLY SER GLY SEQRES 6 L 106 SER GLY THR SER TYR SER LEU THR ILE SER ARG VAL GLU SEQRES 7 L 106 ALA GLU ASP ALA ALA THR TYR TYR CYS GLN GLN TRP SER SEQRES 8 L 106 SER ASP PRO PRO THR PHE GLY SER GLY THR LYS LEU GLU SEQRES 9 L 106 ILE LYS HET NAG A 1 14 HET NAG A 2 14 HET NAG L 201 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 8 NAG 3(C8 H15 N O6) HELIX 1 AA1 THR D 28 TYR D 32 5 5 HELIX 2 AA2 ALA D 87 SER D 91 5 5 HELIX 3 AA3 LYS E 74 SER E 76 5 3 HELIX 4 AA4 THR E 87 SER E 91 5 5 HELIX 5 AA5 ARG F 403 ILE F 410 5 8 HELIX 6 AA6 THR H 28 TYR H 32 5 5 SHEET 1 AA1 4 THR C 5 GLN C 6 0 SHEET 2 AA1 4 ILE C 21 LYS C 24 -1 O LYS C 24 N THR C 5 SHEET 3 AA1 4 ASP C 70 LEU C 73 -1 O LEU C 73 N ILE C 21 SHEET 4 AA1 4 SER C 65 SER C 67 -1 N SER C 65 O THR C 72 SHEET 1 AA2 6 PHE C 10 SER C 12 0 SHEET 2 AA2 6 THR C 102 GLU C 105 1 O GLU C 105 N LEU C 11 SHEET 3 AA2 6 ASP C 85 TYR C 86 -1 N TYR C 86 O THR C 102 SHEET 4 AA2 6 ALA C 34 GLN C 38 -1 N GLN C 38 O ASP C 85 SHEET 5 AA2 6 LYS C 45 SER C 49 -1 O LYS C 45 N GLN C 37 SHEET 6 AA2 6 THR C 53 ARG C 54 -1 O THR C 53 N SER C 49 SHEET 1 AA3 4 LEU D 4 SER D 7 0 SHEET 2 AA3 4 CYS D 22 SER D 25 -1 O LYS D 23 N GLN D 6 SHEET 3 AA3 4 THR D 78 ALA D 79 -1 O ALA D 79 N CYS D 22 SHEET 4 AA3 4 ALA D 72 ASP D 73 -1 N ASP D 73 O THR D 78 SHEET 1 AA4 2 VAL D 18 LYS D 19 0 SHEET 2 AA4 2 GLN D 82 LEU D 83 -1 O LEU D 83 N VAL D 18 SHEET 1 AA5 5 ARG D 59 TYR D 60 0 SHEET 2 AA5 5 GLU D 46 ILE D 51 -1 N ALA D 50 O ARG D 59 SHEET 3 AA5 5 MET D 34 GLN D 39 -1 N MET D 34 O ILE D 51 SHEET 4 AA5 5 ALA D 92 ARG D 99 -1 O ALA D 97 N GLN D 35 SHEET 5 AA5 5 PHE D 107 TYR D 109 -1 O ALA D 108 N ARG D 98 SHEET 1 AA6 5 ARG D 59 TYR D 60 0 SHEET 2 AA6 5 GLU D 46 ILE D 51 -1 N ALA D 50 O ARG D 59 SHEET 3 AA6 5 MET D 34 GLN D 39 -1 N MET D 34 O ILE D 51 SHEET 4 AA6 5 ALA D 92 ARG D 99 -1 O ALA D 97 N GLN D 35 SHEET 5 AA6 5 THR D 114 VAL D 116 -1 O THR D 114 N TYR D 94 SHEET 1 AA7 4 GLN E 3 GLN E 5 0 SHEET 2 AA7 4 LEU E 20 SER E 25 -1 O SER E 25 N GLN E 3 SHEET 3 AA7 4 THR E 78 LEU E 83 -1 O ALA E 79 N CYS E 22 SHEET 4 AA7 4 ALA E 68 ASP E 73 -1 N ILE E 69 O GLN E 82 SHEET 1 AA8 2 ALA E 9 VAL E 12 0 SHEET 2 AA8 2 THR E 114 VAL E 117 1 O THR E 116 N VAL E 12 SHEET 1 AA9 5 HIS E 59 TYR E 60 0 SHEET 2 AA9 5 LEU E 45 ILE E 51 -1 N ARG E 50 O HIS E 59 SHEET 3 AA9 5 MET E 34 GLN E 39 -1 N LYS E 38 O GLU E 46 SHEET 4 AA9 5 VAL E 93 ARG E 98 -1 O VAL E 93 N GLN E 39 SHEET 5 AA9 5 TYR E 108 TRP E 109 -1 O TYR E 108 N ARG E 98 SHEET 1 AB1 5 ARG F 357 ILE F 358 0 SHEET 2 AB1 5 VAL F 395 SER F 399 -1 O VAL F 395 N ILE F 358 SHEET 3 AB1 5 VAL F 511 LEU F 513 -1 O VAL F 512 N ASP F 398 SHEET 4 AB1 5 CYS F 432 ALA F 435 -1 N ILE F 434 O VAL F 511 SHEET 5 AB1 5 THR F 376 CYS F 379 -1 N THR F 376 O ALA F 435 SHEET 1 AB2 2 ARG F 452 ARG F 454 0 SHEET 2 AB2 2 LEU F 492 SER F 494 -1 O GLN F 493 N TYR F 453 SHEET 1 AB3 2 SER G 10 MET G 13 0 SHEET 2 AB3 2 LYS G 109 ILE G 112 1 O LYS G 109 N LEU G 11 SHEET 1 AB4 3 VAL G 19 THR G 20 0 SHEET 2 AB4 3 THR G 80 ILE G 81 -1 O ILE G 81 N VAL G 19 SHEET 3 AB4 3 PHE G 68 ILE G 69 -1 N ILE G 69 O THR G 80 SHEET 1 AB5 3 PRO G 50 LEU G 52 0 SHEET 2 AB5 3 ALA G 40 GLN G 44 -1 N GLN G 43 O LYS G 51 SHEET 3 AB5 3 CYS G 94 GLN G 95 -1 O GLN G 95 N ALA G 40 SHEET 1 AB6 2 VAL G 54 TYR G 55 0 SHEET 2 AB6 2 THR G 59 ARG G 60 -1 O THR G 59 N TYR G 55 SHEET 1 AB7 4 GLN H 3 GLN H 6 0 SHEET 2 AB7 4 SER H 21 SER H 25 -1 O LYS H 23 N GLN H 5 SHEET 3 AB7 4 THR H 78 LEU H 83 -1 O ALA H 79 N CYS H 22 SHEET 4 AB7 4 ALA H 68 THR H 71 -1 N THR H 71 O TYR H 80 SHEET 1 AB8 3 GLU H 10 VAL H 12 0 SHEET 2 AB8 3 THR H 112 VAL H 116 1 O THR H 115 N GLU H 10 SHEET 3 AB8 3 ALA H 92 TYR H 94 -1 N TYR H 94 O THR H 112 SHEET 1 AB9 5 SER H 58 TYR H 60 0 SHEET 2 AB9 5 LEU H 45 ILE H 51 -1 N TRP H 50 O ILE H 59 SHEET 3 AB9 5 TYR H 33 GLN H 39 -1 N LYS H 38 O GLU H 46 SHEET 4 AB9 5 CYS H 96 GLU H 99 -1 O GLU H 99 N TYR H 33 SHEET 5 AB9 5 PHE H 105 TRP H 108 -1 O PHE H 107 N GLY H 98 SHEET 1 AC1 2 ILE L 10 SER L 12 0 SHEET 2 AC1 2 LYS L 102 GLU L 104 1 O LYS L 102 N LEU L 11 SHEET 1 AC2 3 VAL L 19 ARG L 24 0 SHEET 2 AC2 3 SER L 69 ILE L 74 -1 O TYR L 70 N CYS L 23 SHEET 3 AC2 3 PHE L 61 SER L 66 -1 N SER L 64 O SER L 71 SHEET 1 AC3 3 PRO L 43 ILE L 47 0 SHEET 2 AC3 3 TRP L 34 GLN L 37 -1 N GLN L 36 O LYS L 44 SHEET 3 AC3 3 THR L 84 CYS L 87 -1 O TYR L 86 N CYS L 35 SSBOND 1 CYS C 23 CYS C 88 1555 1555 2.03 SSBOND 2 CYS D 22 CYS D 96 1555 1555 2.03 SSBOND 3 CYS E 22 CYS E 96 1555 1555 2.15 SSBOND 4 CYS F 379 CYS F 432 1555 1555 2.03 SSBOND 5 CYS F 480 CYS F 488 1555 1555 2.03 SSBOND 6 CYS G 23 CYS G 94 1555 1555 2.03 SSBOND 7 CYS H 22 CYS H 96 1555 1555 2.03 LINK ND2 ASN F 343 C1 NAG A 1 1555 1555 1.43 LINK ND2 ASN L 26 C1 NAG L 201 1555 1555 1.44 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.45 CISPEP 1 TYR C 94 PRO C 95 0 2.81 CISPEP 2 THR G 100 PRO G 101 0 6.13 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000